PPM Services SA

PPM Services SA (also written PPM Service S.A. and PPM (Pharma Project Management) Services S.A.) is a private Swiss company founded in 2014 and based in Morbio Inferiore, in the canton of Ticino. It operates as a specialised pharmaceutical project-management and drug-development organisation rather than as a conventional drug manufacturer. Its stated focus is the management of new therapeutic agents for the treatment and management of immune-inflammatory-mediated diseases, covering the development path from target validation up to Phase II proof-of-concept clinical studies. The company's modus operandi is built on partnerships. On the discovery side, PPM Services SA works with universities and research institutes to source innovative targets. On the development side, it collaborates with contract manufacturing organisations (CMOs) and contract research organisations (CROs) to complete the development process up to clinical phases. Outsourcing is used as a strategic tool across R&D, manufacturing and distribution, while PPM Services SA retains strategic planning and management of CMC (chemistry, manufacturing and controls), nonclinical, regulatory and clinical activities. It also interacts directly with competent authorities such as the FDA, EMA and local regulators on R&D plans. Rather than maintaining a large fixed internal organisation, PPM Services SA creates ad-hoc, project-specific teams. These teams can include scientists from academies and research institutes, key opinion leaders (KOLs), and ad-hoc consultants selected worldwide for project-specific expertise, alongside clinical CROs operating globally and locally. The company describes its role as project management, group leading, strategic planning and interaction with competent authorities. The leadership team listed on the company's website includes Salvatore Bellinvia as Managing Director & Clinical Management, Francesca Viti as R&D Director, Salvatore Demartis as CMC Manager, Helena Larsson in Quality Assurance Management, and Marianna Gabriele as Office Manager. The company presents itself as a connector between research and development and partnerships, emphasising collaboration with the brightest people and organisations. As a private company, PPM Services SA does not appear to be listed on a stock exchange. Its business is positioned in the niche between academic research and full-scale pharmaceutical development, offering project management and strategic oversight for early-stage therapeutic programmes in immunology and inflammation.

PPM Services SA was founded in 2014 as a private company based in Ticino, Switzerland. From its inception, the company positioned itself not as a traditional pharmaceutical manufacturer but as a project-management and development organisation focused on new therapeutic agents for immune-inflammatory-mediated diseases. Its stated scope runs from target validation through to Phase II proof-of-concept clinical studies. The company's operating model was built around partnerships rather than a large internal infrastructure. It established long-term collaborations with universities and research institutes to source innovative targets, and with contract manufacturing organisations (CMOs) and contract research organisations (CROs) to execute the development process up to clinical phases. Outsourcing was adopted as a strategic tool across R&D, manufacturing and distribution, while PPM Services SA retained strategic planning and management of CMC, nonclinical, regulatory and clinical activities. The company also interacts directly with competent authorities such as the FDA, EMA and local regulators regarding R&D plans. A distinctive feature of PPM Services SA is its use of ad-hoc, project-specific teams. These teams can include scientists from academies and research institutes, key opinion leaders, and ad-hoc consultants selected worldwide for project-specific expertise, alongside global and local clinical CROs. The company describes its role as project management, group leading, strategic planning and interaction with competent authorities. As of the company's website information, the leadership team includes Salvatore Bellinvia as Managing Director & Clinical Management, Francesca Viti as R&D Director, Salvatore Demartis as CMC Manager, Helena Larsson in Quality Assurance Management, and Marianna Gabriele as Office Manager. The company is headquartered in Morbio Inferiore, in the canton of Ticino, Switzerland. It remains a private company and does not appear to be listed on a stock exchange.

• 2014

  PPM Services SA founded as a private company based in Ticino, Switzerland.

Specialised pharmaceutical project-management and drug-development partner for early-stage immune-inflammatory programmes, bridging academic research and CRO/CMO execution.

• Pharmaceutical project management

  Management of new therapeutic agents for immune-inflammatory-mediated diseases from target validation to Phase II proof of concept.

• CMC, nonclinical, regulatory and clinical management

  Strategic planning and management of CMC, nonclinical, regulatory and clinical activities, with direct interaction with competent authorities (FDA, EMA, local).

• Ad-hoc project-specific teams

  Teams including academic scientists, KOLs and worldwide consultants selected for project-specific expertise.

1. 1PPM Services official websiteppmservices.ch
2. 2Wikidata: PPM Services SA (Switzerland)wikidata.org